Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Cilostazol"" wg kryterium: Temat


Tytuł :
A new simple method for quantification of cilostazol and its active metabolite in human plasma by LC-MS/MS: Application to pharmacokinetics of cilostazol associated with CYP genotypes in healthy Chinese population.
Autorzy :
Shen Y; Center of Clinical Pharmacology, School of Medicine, The Second Affiliated Hospital of Zhejiang University, Zhejiang, Hangzhou, China.
Jiang B; Center of Clinical Pharmacology, School of Medicine, The Second Affiliated Hospital of Zhejiang University, Zhejiang, Hangzhou, China.
Hu X; Center of Clinical Pharmacology, School of Medicine, The Second Affiliated Hospital of Zhejiang University, Zhejiang, Hangzhou, China.
Chen J; Center of Clinical Pharmacology, School of Medicine, The Second Affiliated Hospital of Zhejiang University, Zhejiang, Hangzhou, China.
Xu Y; Center of Clinical Pharmacology, School of Medicine, The Second Affiliated Hospital of Zhejiang University, Zhejiang, Hangzhou, China.
Ruan Z; Center of Clinical Pharmacology, School of Medicine, The Second Affiliated Hospital of Zhejiang University, Zhejiang, Hangzhou, China.
Yang D; Center of Clinical Pharmacology, School of Medicine, The Second Affiliated Hospital of Zhejiang University, Zhejiang, Hangzhou, China.
Lou H; Center of Clinical Pharmacology, School of Medicine, The Second Affiliated Hospital of Zhejiang University, Zhejiang, Hangzhou, China.
Pokaż więcej
Źródło :
Biomedical chromatography : BMC [Biomed Chromatogr] 2021 Oct; Vol. 35 (10), pp. e5150. Date of Electronic Publication: 2021 May 25.
Typ publikacji :
Journal Article
MeSH Terms :
Chromatography, Liquid/*methods
Cilostazol/*analogs & derivatives
Cilostazol/*blood
Cytochrome P-450 Enzyme System/*genetics
Tandem Mass Spectrometry/*methods
China ; Cilostazol/chemistry ; Cilostazol/pharmacokinetics ; Genotype ; Humans ; Linear Models ; Male ; Reproducibility of Results ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Cilostazol administration for subarachnoid hemorrhage: A meta-analysis of randomized controlled trials.
Autorzy :
Chen J; Department of Critical Care Medicine, Daye People's Hospital, China. Electronic address: .
Tang P; Operating Room, Suizhou Hospital, Hubei University of Medicine, China. Electronic address: .
Fu X; Chongqing Medical and Pharmaceutical College, China. Electronic address: .
Pokaż więcej
Źródło :
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] 2021 Jul; Vol. 89, pp. 305-310. Date of Electronic Publication: 2021 May 21.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Cilostazol/*therapeutic use
Subarachnoid Hemorrhage/*drug therapy
Vasodilator Agents/*therapeutic use
Cilostazol/administration & dosage ; Cilostazol/adverse effects ; Humans ; Randomized Controlled Trials as Topic ; Treatment Outcome ; Vasoconstriction ; Vasodilator Agents/administration & dosage ; Vasodilator Agents/adverse effects
Czasopismo naukowe
Tytuł :
Identification and functional study of genetic polymorphisms in cyclic nucleotide phosphodiesterase 3A (PDE3A).
Autorzy :
Kim YR; Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Inje University, Busan, South Korea.
Yi M; Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Inje University, Busan, South Korea.; Pharmacogenetics Section, Reproductive and Developmental Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA.
Cho SA; Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Inje University, Busan, South Korea.
Kim WY; Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Inje University, Busan, South Korea.
Min J; Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina, USA.
Shin JG; Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Inje University, Busan, South Korea.; Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Inje University College of Medicine, Inje University, Busan, 47392, South Korea.
Lee SJ; Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Inje University, Busan, South Korea.
Pokaż więcej
Źródło :
Annals of human genetics [Ann Hum Genet] 2021 Mar; Vol. 85 (2), pp. 80-91. Date of Electronic Publication: 2020 Nov 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cilostazol/*administration & dosage
Cyclic AMP/*genetics
Cyclic Nucleotide Phosphodiesterases, Type 3/*genetics
Platelet Activation/*drug effects
Adult ; Blood Platelets/drug effects ; Cilostazol/adverse effects ; Dose-Response Relationship, Drug ; Female ; Humans ; Male ; Mutation, Missense/genetics ; Myocytes, Cardiac/drug effects ; Myocytes, Cardiac/metabolism ; Platelet Activation/genetics ; Platelet Aggregation Inhibitors/administration & dosage ; Platelet Aggregation Inhibitors/adverse effects ; Polymorphism, Genetic/genetics ; Signal Transduction/drug effects ; Whole Exome Sequencing
Czasopismo naukowe
Tytuł :
Cilostazol Versus Aspirin for Secondary Stroke Prevention: Systematic Review and Meta-Analysis.
Autorzy :
Lin MP; Department of Neurology, Mayo Clinic, Jacksonville, FL, United States. Electronic address: .
Meschia JF; Department of Neurology, Mayo Clinic, Jacksonville, FL, United States.
Gopal N; Department of Neurology, Mayo Clinic, Jacksonville, FL, United States.
Barrett KM; Department of Neurology, Mayo Clinic, Jacksonville, FL, United States.
Ross OA; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, United States.
Ertekin-Taner N; Department of Neurology, Mayo Clinic, Jacksonville, FL, United States; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, United States.
Brott TG; Department of Neurology, Mayo Clinic, Jacksonville, FL, United States.
Pokaż więcej
Źródło :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2021 Mar; Vol. 30 (3), pp. 105581. Date of Electronic Publication: 2020 Dec 31.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Secondary Prevention*
Aspirin/*therapeutic use
Cilostazol/*therapeutic use
Ischemic Stroke/*prevention & control
Platelet Aggregation Inhibitors/*therapeutic use
Aged ; Anti-Inflammatory Agents/therapeutic use ; Aspirin/adverse effects ; Cilostazol/adverse effects ; Female ; Humans ; Intracranial Hemorrhages/chemically induced ; Ischemic Stroke/diagnosis ; Ischemic Stroke/epidemiology ; Male ; Platelet Aggregation Inhibitors/adverse effects ; Randomized Controlled Trials as Topic ; Recurrence ; Risk Assessment ; Risk Factors ; Treatment Outcome ; Vasodilator Agents/therapeutic use
Czasopismo naukowe
Tytuł :
Literature review and meta-analysis of the efficacy of cilostazol on limb salvage rates after infrainguinal endovascular and open revascularization.
Autorzy :
Desai K; Section of Vascular Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Mo.
Han B; Section of Vascular Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Mo.
Kuziez L; Saint Louis College of Pharmacy, St. Louis, Mo.
Yan Y; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Mo.
Zayed MA; Section of Vascular Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Mo; Division of Molecular Cell Biology, Washington University School of Medicine, St. Louis, Mo; McKelvey School of Engineering, Department of Biomedical Engineering, Washington University, St. Louis, Mo; St. Louis Veterans Affairs Medical Center, St. Louis, Mo. Electronic address: .
Pokaż więcej
Źródło :
Journal of vascular surgery [J Vasc Surg] 2021 Feb; Vol. 73 (2), pp. 711-721.e3. Date of Electronic Publication: 2020 Sep 04.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Endovascular Procedures*/adverse effects
Endovascular Procedures*/mortality
Limb Salvage*
Vascular Grafting*/adverse effects
Vascular Grafting*/mortality
Cilostazol/*therapeutic use
Ischemia/*therapy
Peripheral Arterial Disease/*therapy
Phosphodiesterase 3 Inhibitors/*therapeutic use
Aged ; Aged, 80 and over ; Amputation ; Cilostazol/adverse effects ; Critical Illness ; Female ; Humans ; Ischemia/diagnosis ; Ischemia/mortality ; Male ; Middle Aged ; Peripheral Arterial Disease/diagnosis ; Peripheral Arterial Disease/mortality ; Phosphodiesterase 3 Inhibitors/adverse effects ; Randomized Controlled Trials as Topic ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Cilostazol Addition to Aspirin could not Reduce the Neurological Deterioration in TOAST Subtypes: ADS Post-Hoc Analysis.
Autorzy :
Aoki J; Department of Neurological Science, Nippon Medical School Graduate School of Medicine, 1-1-5, Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan; Department of Stroke Medicine, Kawasaki Medical School, Kurashiki, Japan. Electronic address: .
Iguchi Y; Department of Neurology, Jikei University School of Medicine, Tokyo, Japan.
Urabe T; Department of Neurology, Juntendo University Urayasu Hospital, Chiba, Japan.
Yamagami H; Department of Neurology, Stroke Center, Kobe City Medical Center General Hospital, Hyogo.
Todo K; Department of Neurology, Stroke Center, Kobe City Medical Center General Hospital, Hyogo.
Fujimoto S; Department of Cerebrovascular Medicine, Stroke Center, Steel Memorial Yawata Hospital, Fukuoka, Japan.
Idomari K; Department of Stroke Medicine, Okinawa Kyodo Hospital, Okinawa, Japan.
Kaneko N; Department of Stroke Medicine, Okinawa Kyodo Hospital, Okinawa, Japan.
Iwanaga T; Department of Stroke Medicine, Okayama Red Cross Hospital, Okayama, Japan.
Terasaki T; Department of Neurology, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan.
Tanaka R; Department of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Yamamoto N; Department of Clinical Neurosciences, Institute of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Tsujino A; Department of Neurology and Strokology, Nagasaki University Hospital, Nagasaki, Japan.
Nomura K; Department of Neurology, Shioda Hospital, Chiba, Japan.
Abe K; Department of Neurology, Okayama University Medical School. Okayama, Japan.
Uno M; Department of Neurosurgery, Kawasaki Medical School, Okayama, Japan.
Okada Y; Department of Cerebrovascular Medicine and Neurology, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan.
Matsuoka H; Department of Cerebrovascular Medicine, NHO Kagoshima Medical Center, Kagoshima, Japan.
Yamagata S; Department of Neurosurgery, Kurashiki Central Hospital, Okayama, Japan.
Yamamoto Y; Department of Neurology, Kyoto Second Red Cross Hospital, Kyoto, Japan.
Yonehara T; Department of Neurology, Stroke Center, Saiseikai Kumamoto Hospital, Kumamoto, Japan.
Inoue T; Department of Stroke Medicine, Kawasaki Medical School General Medical Center, Kawasaki Medical School, Okayama, Japan.
Yagita Y; Department of Stroke Medicine, Kawasaki Medical School, Kurashiki, Japan.
Kimura K; Department of Neurological Science, Nippon Medical School Graduate School of Medicine, 1-1-5, Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan; Department of Stroke Medicine, Kawasaki Medical School, Kurashiki, Japan.
Pokaż więcej
Corporate Authors :
ADS investigators
Źródło :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2021 Feb; Vol. 30 (2), pp. 105494. Date of Electronic Publication: 2020 Dec 02.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study
MeSH Terms :
Dual Anti-Platelet Therapy*/adverse effects
Aspirin/*therapeutic use
Cilostazol/*therapeutic use
Platelet Aggregation Inhibitors/*therapeutic use
Stroke/*drug therapy
Aged ; Aspirin/adverse effects ; Cilostazol/adverse effects ; Disease Progression ; Female ; Humans ; Japan ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/adverse effects ; Randomized Controlled Trials as Topic ; Recurrence ; Registries ; Retrospective Studies ; Risk Factors ; Stroke/diagnosis ; Stroke/physiopathology ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Efficacy and Safety of Adjunctive Cilostazol to Clopidogrel-Treated Diabetic Patients With Symptomatic Lower Extremity Artery Disease in the Prevention of Ischemic Vascular Events.
Autorzy :
Kalantzi K; Atherothrombosis Research Center Laboratory of Biochemistry Department of Chemistry University of Ioannina Greece.
Tentolouris N; 1st Department of Propaedeutic Internal Medicine Medical School National and Kapodistrian University of Athens Greece.
Melidonis AJ; Diabetes Center Metropolitan Hospital Athens Greece.
Papadaki S; Atherothrombosis Research Center Laboratory of Biochemistry Department of Chemistry University of Ioannina Greece.
Peroulis M; Atherothrombosis Research Center Laboratory of Biochemistry Department of Chemistry University of Ioannina Greece.
Amantos KA; Diabetes Center Metropolitan Hospital Athens Greece.
Andreopoulos G; Diabetes Center Metropolitan Hospital Athens Greece.
Bellos GI; Koropi Health Center Attica Greece.
Boutel D; General Hospital of Giannitsa Greece.
Bristianou M; Department of Internal Medicine General Hospital of Lamia Greece.
Chrisis D; 3rd Internal Medicine Department and Diabetes Center General Hospital of Nikaia Athens Greece.
Dimitsikoglou NA; Atherothrombosis Research Center Laboratory of Biochemistry Department of Chemistry University of Ioannina Greece.
Doupis J; Atherothrombosis Research Center Laboratory of Biochemistry Department of Chemistry University of Ioannina Greece.
Georgopoulou C; Diabetes Center Metropolitan Hospital Athens Greece.
Gkintikas SA; Division of Endocrinology and Metabolism and Diabetes Center First Department of Internal Medicine Medical School Aristotle University of ThessalonikiAHEPA University Hospital Thessaloniki Greece.
Iraklianou S; 3rd Department of Internal Medicine Center General Hospital 'Tzaneio,' Piraeus Greece.
Kanellas Κ; 3rd Department of Internal Medicine Center General Hospital 'Tzaneio,' Piraeus Greece.
Kotsa K; Division of Endocrinology and Metabolism and Diabetes Center First Department of Internal Medicine Medical School Aristotle University of ThessalonikiAHEPA University Hospital Thessaloniki Greece.
Koufakis T; Division of Endocrinology and Metabolism and Diabetes Center First Department of Internal Medicine Medical School Aristotle University of ThessalonikiAHEPA University Hospital Thessaloniki Greece.
Kouroglou M; General Regional Hospital of Mytilene Greece.
Koutsovasilis AG; 3rd Internal Medicine Department and Diabetes Center General Hospital of Nikaia Athens Greece.
Lanaras L; Department of Internal Medicine General Hospital of Lamia Greece.
Liouri E; 3rd Internal Medicine Department and Diabetes Center General Hospital of Nikaia Athens Greece.
Lixouriotis C; Health Center of Distomo Voiotia Greece.
Lykoudi A; 3rd Internal Medicine Department and Diabetes Center General Hospital of Nikaia Athens Greece.
Mandalaki E; Atherothrombosis Research Center Laboratory of Biochemistry Department of Chemistry University of Ioannina Greece.
Papageorgiou E; 3rd Internal Medicine Department and Diabetes Center General Hospital of Nikaia Athens Greece.
Papanas N; Second Department of Internal Medicine Democritus University of Thrace Alexandroupolis Greece.
Rigas S; 3rd Internal Medicine Department and Diabetes Center General Hospital of Nikaia Athens Greece.
Stamatelatou MI; Internal Medicine Clinic General Hospital of Sitia Crete Greece.
Triantafyllidis I; Atherothrombosis Research Center Laboratory of Biochemistry Department of Chemistry University of Ioannina Greece.
Trikkalinou A; Diabetes Center Metropolitan Hospital Athens Greece.
Tsouka AN; Atherothrombosis Research Center Laboratory of Biochemistry Department of Chemistry University of Ioannina Greece.
Zacharopoulou O; Diabetes Center Metropolitan Hospital Athens Greece.
Zoupas C; Diabetes Center Metropolitan Hospital Athens Greece.
Tsolakis I; Vascular Surgery Department University of Patras Greece.
Tselepis AD; Atherothrombosis Research Center Laboratory of Biochemistry Department of Chemistry University of Ioannina Greece.
Pokaż więcej
Źródło :
Journal of the American Heart Association [J Am Heart Assoc] 2021 Jan 05; Vol. 10 (1), pp. e018184. Date of Electronic Publication: 2020 Dec 17.
Typ publikacji :
Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Brain Ischemia*/diagnosis
Brain Ischemia*/etiology
Brain Ischemia*/mortality
Brain Ischemia*/prevention & control
Cilostazol*/administration & dosage
Cilostazol*/adverse effects
Clopidogrel*/administration & dosage
Clopidogrel*/adverse effects
Intermittent Claudication*/complications
Intermittent Claudication*/therapy
Myocardial Infarction*/diagnosis
Myocardial Infarction*/etiology
Myocardial Infarction*/mortality
Myocardial Infarction*/prevention & control
Diabetes Mellitus, Type 2/*complications
Aged ; Drug Monitoring/methods ; Drug Therapy, Combination/methods ; Female ; Humans ; Lower Extremity/blood supply ; Lower Extremity/physiopathology ; Male ; Outcome and Process Assessment, Health Care ; Platelet Aggregation Inhibitors/administration & dosage ; Platelet Aggregation Inhibitors/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Osmotic pump tablets with solid dispersions synergized by hydrophilic polymers and mesoporous silica improve in vitro/in vivo performance of cilostazol.
Autorzy :
Zhang S; Department of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, China.
Sun Y; Department of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, China.
Zhou L; Department of Traditional Chinese Medicine, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, China.
Jiang Z; Department of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, China.
Yang X; Department of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, China. Electronic address: .
Feng Y; Grace Materials Technologies, F19, K.Wah Center, No. 1010, Middle Huai Hai Road, Xu Hui District, Shanghai 200031, China.
Pokaż więcej
Źródło :
International journal of pharmaceutics [Int J Pharm] 2020 Oct 15; Vol. 588, pp. 119759. Date of Electronic Publication: 2020 Aug 13.
Typ publikacji :
Journal Article
MeSH Terms :
Cilostazol*
Polymers*
Silicon Dioxide*
Animals ; Biological Availability ; Dogs ; Solubility ; Spectroscopy, Fourier Transform Infrared ; Tablets
Czasopismo naukowe
Tytuł :
Possible mechanisms mediating the protective effect of cilostazol in L-arginine induced acute pancreatitis in rats: role of cGMP, cAMP, and HO-1.
Autorzy :
Abdel-Aziz AM; Departments of Pharmacology, Faculty of Medicine, Minia University, Minia, 61511, Egypt.
Rifaai RA; Departments of Histology and cell biology, Faculty of Medicine, Minia University, Minia, 61511, Egypt.
Abdel-Gaber SA; Departments of Pharmacology, Faculty of Medicine, Minia University, Minia, 61511, Egypt. .
Pokaż więcej
Źródło :
Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2020 Oct; Vol. 393 (10), pp. 1859-1870. Date of Electronic Publication: 2020 May 19.
Typ publikacji :
Journal Article
MeSH Terms :
Arginine/*toxicity
Cilostazol/*therapeutic use
Cyclic AMP/*metabolism
Cyclic GMP/*metabolism
Heme Oxygenase (Decyclizing)/*metabolism
Pancreatitis/*metabolism
Animals ; Cilostazol/pharmacology ; Male ; Oxidative Stress/drug effects ; Oxidative Stress/physiology ; Pancreatitis/chemically induced ; Pancreatitis/prevention & control ; Phosphodiesterase 3 Inhibitors/pharmacology ; Phosphodiesterase 3 Inhibitors/therapeutic use ; Rats ; Rats, Wistar
Czasopismo naukowe
Tytuł :
Positive chronotropic effects of theophylline and cilostazol in patients with symptomatic sick sinus syndrome who have declined permanent pacing.
Autorzy :
Jin IT; Department of Cardiovascular Medicine, Heart Center of Chonnam National University Hospital, Chonnam National University Medical School, Chonnam National University, 671 Jeabongro, Dong-gu, Gwangju 61469, Korea.
Yoon N; Department of Cardiovascular Medicine, Heart Center of Chonnam National University Hospital, Chonnam National University Medical School, Chonnam National University, 671 Jeabongro, Dong-gu, Gwangju 61469, Korea.
Jeong HK; Department of Cardiovascular Medicine, Heart Center of Chonnam National University Hospital, Chonnam National University Medical School, Chonnam National University, 671 Jeabongro, Dong-gu, Gwangju 61469, Korea.
Lee KH; Department of Cardiovascular Medicine, Heart Center of Chonnam National University Hospital, Chonnam National University Medical School, Chonnam National University, 671 Jeabongro, Dong-gu, Gwangju 61469, Korea.
Park HW; Department of Cardiovascular Medicine, Heart Center of Chonnam National University Hospital, Chonnam National University Medical School, Chonnam National University, 671 Jeabongro, Dong-gu, Gwangju 61469, Korea.
Cho JG; Department of Cardiovascular Medicine, Heart Center of Chonnam National University Hospital, Chonnam National University Medical School, Chonnam National University, 671 Jeabongro, Dong-gu, Gwangju 61469, Korea.
Pokaż więcej
Źródło :
Reviews in cardiovascular medicine [Rev Cardiovasc Med] 2020 Sep 30; Vol. 21 (3), pp. 473-480.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Cardiovascular Agents/*therapeutic use
Cilostazol/*therapeutic use
Heart Rate/*drug effects
Sick Sinus Syndrome/*drug therapy
Theophylline/*therapeutic use
Aged ; Cardiac Pacing, Artificial ; Cardiovascular Agents/adverse effects ; Cilostazol/adverse effects ; Drug Substitution ; Female ; Humans ; Male ; Middle Aged ; Recovery of Function ; Retrospective Studies ; Sick Sinus Syndrome/diagnosis ; Sick Sinus Syndrome/physiopathology ; Theophylline/adverse effects ; Time Factors ; Treatment Outcome ; Treatment Refusal
Czasopismo naukowe
Tytuł :
Cilostazol-based triple versus potent P2Y12 inhibitor-based dual antiplatelet therapy in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Autorzy :
Kim W; Cardiovascular Center, Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea.
Kim JS; Division of Cardiology, Department of Internal Medicine, Korea University Ansan Hospital, Ansan-si, Republic of Korea.
Rha SW; Cardiovascular Center, Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea. .; Cardiovascular Intervention Research Institute, Seoul, Republic of Korea. .
Choi BG; College of Medicine, Institute of Health Science, Korea University, Seoul, Republic of Korea.
Jang WY; Cardiovascular Center, Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea.
Kang DO; Cardiovascular Center, Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea.
Park Y; Cardiovascular Center, Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea.
Choi JY; Cardiovascular Center, Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea.
Roh SY; Cardiovascular Center, Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea.
Na JO; Cardiovascular Center, Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea.
Choi CU; Cardiovascular Center, Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea.
Kim EJ; Cardiovascular Center, Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea.
Park CG; Cardiovascular Center, Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea.
Seo HS; Cardiovascular Center, Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea.
Choi SY; Cardiovascular Center, Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea.
Byun JK; Cardiovascular Center, Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea.
Cha J; Cardiovascular Center, Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea.
Oh DJ; Cardiovascular Intervention Research Institute, Seoul, Republic of Korea.
Jeong MH; Heart Center of Chonnam, National University Hospital, Gwangju, Republic of Korea.
Pokaż więcej
Corporate Authors :
other Korea Acute Myocardial Infarction Registry (KAMIR) investigators
Źródło :
Heart and vessels [Heart Vessels] 2020 Sep; Vol. 35 (9), pp. 1181-1192. Date of Electronic Publication: 2020 Apr 08.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Dual Anti-Platelet Therapy*/adverse effects
Percutaneous Coronary Intervention*/adverse effects
Aspirin/*administration & dosage
Cilostazol/*administration & dosage
Myocardial Infarction/*therapy
Platelet Aggregation Inhibitors/*administration & dosage
Purinergic P2Y Receptor Antagonists/*administration & dosage
Aged ; Asian Continental Ancestry Group ; Aspirin/adverse effects ; Cilostazol/adverse effects ; Clopidogrel/administration & dosage ; Databases, Factual ; Female ; Hemorrhage/chemically induced ; Hemorrhage/ethnology ; Humans ; Male ; Middle Aged ; Myocardial Infarction/diagnostic imaging ; Myocardial Infarction/ethnology ; Platelet Aggregation Inhibitors/adverse effects ; Prasugrel Hydrochloride/administration & dosage ; Purinergic P2Y Receptor Antagonists/adverse effects ; Registries ; Republic of Korea/epidemiology ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Ticagrelor/administration & dosage ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Molecularly imprinted polymer nanoparticles-based electrochemical chemosensors for selective determination of cilostazol and its pharmacologically active primary metabolite in human plasma.
Autorzy :
Jyoti; Institute of Physical Chemistry, Polish Academy of Sciences (IPC PAS), Kasprzaka 44/52, 01-224, Warsaw, Poland.
Gonzato C; Université de Technologie de Compiègne, CNRS Laboratory for Enzyme and Cell Engineering UMR 7025, Rue du Docteur Schweitzer, 60203, Compiègne, France.
Żołek T; Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-097, Warsaw, Poland.
Maciejewska D; Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-097, Warsaw, Poland.
Kutner A; Department of Bioanalysis and Drug Analysis, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-097, Warsaw, Poland.
Merlier F; Université de Technologie de Compiègne, CNRS Laboratory for Enzyme and Cell Engineering UMR 7025, Rue du Docteur Schweitzer, 60203, Compiègne, France.
Haupt K; Université de Technologie de Compiègne, CNRS Laboratory for Enzyme and Cell Engineering UMR 7025, Rue du Docteur Schweitzer, 60203, Compiègne, France. Electronic address: .
Sharma PS; Institute of Physical Chemistry, Polish Academy of Sciences (IPC PAS), Kasprzaka 44/52, 01-224, Warsaw, Poland.
Noworyta KR; Institute of Physical Chemistry, Polish Academy of Sciences (IPC PAS), Kasprzaka 44/52, 01-224, Warsaw, Poland. Electronic address: .
Kutner W; Institute of Physical Chemistry, Polish Academy of Sciences (IPC PAS), Kasprzaka 44/52, 01-224, Warsaw, Poland; Faculty of Mathematics and Natural Sciences. School of Sciences, Cardinal Stefan Wyszynski University in Warsaw, Woycickiego 1/3, 01-815, Warsaw, Poland. Electronic address: .
Pokaż więcej
Źródło :
Biosensors & bioelectronics [Biosens Bioelectron] 2021 Dec 01; Vol. 193, pp. 113542. Date of Electronic Publication: 2021 Aug 05.
Typ publikacji :
Journal Article
MeSH Terms :
Biosensing Techniques*
Molecular Imprinting*
Nanoparticles*
Pharmaceutical Preparations*
Cilostazol ; Electrochemical Techniques ; Electrodes ; Humans ; Limit of Detection ; Molecularly Imprinted Polymers
Czasopismo naukowe
Tytuł :
Phosphodiesterase (1, 3 & 5) inhibitors attenuate diclofenac-induced acute kidney toxicity in rats.
Autorzy :
Wadie W; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: .
Abdel-Razek NS; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Salem HA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2021 Jul 15; Vol. 277, pp. 119506. Date of Electronic Publication: 2021 Apr 15.
Typ publikacji :
Journal Article
MeSH Terms :
Acute Kidney Injury/*metabolism
Phosphodiesterase Inhibitors/*pharmacology
Acute Kidney Injury/drug therapy ; Acute Kidney Injury/pathology ; Animals ; Blood Urea Nitrogen ; Cilostazol/pharmacology ; Creatinine/metabolism ; Diclofenac/adverse effects ; Diclofenac/pharmacology ; Kidney/pathology ; Male ; NF-kappa B/metabolism ; Pentoxifylline/pharmacology ; Phosphodiesterase Inhibitors/metabolism ; Phosphoric Diester Hydrolases/metabolism ; Rats ; Rats, Wistar ; Sildenafil Citrate/pharmacology ; Toll-Like Receptor 4/metabolism ; Tumor Necrosis Factor-alpha/metabolism ; Vinca Alkaloids/pharmacology
Czasopismo naukowe
Tytuł :
Microbleeds and clinical outcome in acute mild stroke patients treated with antiplatelet therapy: ADS post-hoc analysis.
Autorzy :
Aoki J; Department of Neurology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan; Department of Stroke Medicine, Kawasaki Medical School, Kurashiki, Japan. Electronic address: .
Iguchi Y; Department of Neurology, Jikei University School of Medicine, Tokyo, Japan.
Urabe T; Department of Neurology, Juntendo University Urayasu Hospital, Chiba, Japan.
Yamagami H; Department of Neurology, Stroke Center, Kobe City Medical Center General Hospital, Hyogo, Japan.
Todo K; Department of Neurology, Stroke Center, Kobe City Medical Center General Hospital, Hyogo, Japan.
Fujimoto S; Department of Cerebrovascular Medicine, Stroke Center, Steel Memorial Yawata Hospital, Fukuoka, Japan.
Idomari K; Department of Stroke Medicine, Okinawa Kyodo Hospital, Okinawa, Japan.
Kaneko N; Department of Stroke Medicine, Okinawa Kyodo Hospital, Okinawa, Japan.
Iwanaga T; Department of Stroke Medicine, Okayama Red Cross Hospital, Okayama, Japan.
Terasaki T; Department of Neurology, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan.
Tanaka R; Department of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Yamamoto N; Department of Clinical Neurosciences, Institute of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Tsujino A; Department of Neurology and Strokology, Nagasaki University Hospital, Nagasaki, Japan.
Nomura K; Department of Neurology, Shioda Hospital, Chiba, Japan.
Abe K; Department of Neurology, Okayama University Medical School. Okayama, Japan.
Uno M; Department of Neurosurgery, Kawasaki Medical School, Okayama, Japan.
Okada Y; Department of Cerebrovascular Medicine and Neurology, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan.
Matsuoka H; Department of Cerebrovascular Medicine, NHO Kagoshima Medical Center, Kagoshima, Japan.
Yamagata S; Department of Neurosurgery, Kurashiki Central Hospital, Okayama, Japan.
Yamamoto Y; Department of Neurology, Kyoto Second Red Cross Hospital, Kyoto, Japan.
Yonehara T; Department of Neurology, Stroke Center, Saiseikai Kumamoto Hospital, Kumamoto, Japan.
Inoue T; Department of Stroke Medicine, Kawasaki Medical School General Medical Center, Kawasaki Medical School, Okayama, Japan.
Yagita Y; Department of Stroke Medicine, Kawasaki Medical School, Kurashiki, Japan.
Kimura K; Department of Neurology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan; Department of Stroke Medicine, Kawasaki Medical School, Kurashiki, Japan.
Pokaż więcej
Źródło :
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] 2021 Jul; Vol. 89, pp. 216-222. Date of Electronic Publication: 2021 May 12.
Typ publikacji :
Journal Article
MeSH Terms :
Microvessels*/diagnostic imaging
Microvessels*/drug effects
Dual Anti-Platelet Therapy/*methods
Multicenter Studies as Topic/*methods
Platelet Aggregation Inhibitors/*administration & dosage
Randomized Controlled Trials as Topic/*methods
Stroke/*drug therapy
Aged ; Aspirin/administration & dosage ; Aspirin/adverse effects ; Cerebral Hemorrhage/chemically induced ; Cerebral Hemorrhage/diagnostic imaging ; Cilostazol/administration & dosage ; Cilostazol/adverse effects ; Female ; Humans ; Magnetic Resonance Imaging/methods ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/adverse effects ; Prospective Studies ; Retrospective Studies ; Risk Factors ; Stroke/diagnostic imaging ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Role of Cilostazol in Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage-A Systematic Review, Meta-Analysis, and Trial Sequential Analysis.
Autorzy :
Bohara S; Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India.
Garg K; Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India. Electronic address: .
Singh Rajpal PM; Department of Anesthesia, Washington University in St. Louis, St. Louis, Missouri, USA.
Kasliwal M; Department of Neurological Surgery, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Pokaż więcej
Źródło :
World neurosurgery [World Neurosurg] 2021 Jun; Vol. 150, pp. 161-170. Date of Electronic Publication: 2021 Feb 23.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Cilostazol/*therapeutic use
Phosphodiesterase 3 Inhibitors/*therapeutic use
Subarachnoid Hemorrhage/*complications
Vasospasm, Intracranial/*prevention & control
Humans ; Randomized Controlled Trials as Topic ; Treatment Outcome ; Vasospasm, Intracranial/etiology
Czasopismo naukowe
Tytuł :
Network Meta-Analysis Comparing the Outcomes of Treatments for Intermittent Claudication Tested in Randomized Controlled Trials.
Autorzy :
Thanigaimani S; The Queensland Research Centre for Peripheral Vascular Disease (QRC-PVD) College of Medicine and Dentistry James Cook University Townsville Queensland Australia.; The Australian Institute of Tropical Health and Medicine James Cook University Townsville Queensland Australia.
Phie J; The Queensland Research Centre for Peripheral Vascular Disease (QRC-PVD) College of Medicine and Dentistry James Cook University Townsville Queensland Australia.; The Australian Institute of Tropical Health and Medicine James Cook University Townsville Queensland Australia.
Sharma C; The Queensland Research Centre for Peripheral Vascular Disease (QRC-PVD) College of Medicine and Dentistry James Cook University Townsville Queensland Australia.
Wong S; The Queensland Research Centre for Peripheral Vascular Disease (QRC-PVD) College of Medicine and Dentistry James Cook University Townsville Queensland Australia.
Ibrahim M; The Queensland Research Centre for Peripheral Vascular Disease (QRC-PVD) College of Medicine and Dentistry James Cook University Townsville Queensland Australia.
Huynh P; The Queensland Research Centre for Peripheral Vascular Disease (QRC-PVD) College of Medicine and Dentistry James Cook University Townsville Queensland Australia.; The Australian Institute of Tropical Health and Medicine James Cook University Townsville Queensland Australia.
Moxon J; The Queensland Research Centre for Peripheral Vascular Disease (QRC-PVD) College of Medicine and Dentistry James Cook University Townsville Queensland Australia.; The Australian Institute of Tropical Health and Medicine James Cook University Townsville Queensland Australia.
Jones R; The Queensland Research Centre for Peripheral Vascular Disease (QRC-PVD) College of Medicine and Dentistry James Cook University Townsville Queensland Australia.; The Australian Institute of Tropical Health and Medicine James Cook University Townsville Queensland Australia.
Golledge J; The Queensland Research Centre for Peripheral Vascular Disease (QRC-PVD) College of Medicine and Dentistry James Cook University Townsville Queensland Australia.; The Australian Institute of Tropical Health and Medicine James Cook University Townsville Queensland Australia.; The Department of Vascular and Endovascular Surgery Townsville University Hospital Townsville Queensland Australia.
Pokaż więcej
Źródło :
Journal of the American Heart Association [J Am Heart Assoc] 2021 May 04; Vol. 10 (9), pp. e019672. Date of Electronic Publication: 2021 Apr 23.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Randomized Controlled Trials as Topic*
Cilostazol/*therapeutic use
Endovascular Procedures/*methods
Exercise Therapy/*methods
Intermittent Claudication/*therapy
Humans ; Network Meta-Analysis ; Treatment Outcome ; Vasodilator Agents/therapeutic use
Czasopismo naukowe
Tytuł :
Cilostazol for Chinese Patients with Aspirin Intolerance after Coronary Drug-Eluting Stent Implantation.
Autorzy :
Dai C; Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Chen Z; Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Fu J; Shanghai Medical College, Fudan University, Shanghai, China.
Qian J; Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Ge J; Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Pokaż więcej
Źródło :
Thrombosis and haemostasis [Thromb Haemost] 2020 May; Vol. 120 (5), pp. 857-865. Date of Electronic Publication: 2020 May 05.
Typ publikacji :
Comparative Study; Journal Article; Observational Study
MeSH Terms :
Drug-Eluting Stents*
Dual Anti-Platelet Therapy*
Aspirin/*therapeutic use
Cilostazol/*therapeutic use
Coronary Artery Disease/*therapy
Percutaneous Coronary Intervention/*instrumentation
Platelet Aggregation Inhibitors/*therapeutic use
Aspirin/adverse effects ; China ; Cilostazol/adverse effects ; Coronary Artery Disease/diagnostic imaging ; Female ; Hemorrhage/chemically induced ; Humans ; Male ; Middle Aged ; Percutaneous Coronary Intervention/adverse effects ; Platelet Aggregation Inhibitors/adverse effects ; Retrospective Studies ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Pharmacokinetic modeling analysis of cilostazol and its active metabolites (OPC-13015 and OPC-13213) after multiple oral doses of cilostazol in healthy Korean volunteers.
Autorzy :
Cui A; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim YH; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Ghim JL; Department of Clinical Pharmacology, Inje University, Busan Paik Hospital, Busan, Republic of Korea.
Ah Jung J; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Cho SH; Department of Clinical Pharmacology, Inha University Hospital, Inha University School of Medicine, Incheon, Republic of Korea.
Choe S; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Choi HY; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Bae KS; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Lim HS; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Pokaż więcej
Źródło :
Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2020 Mar; Vol. 50 (3), pp. 288-296. Date of Electronic Publication: 2019 Jul 03.
Typ publikacji :
Journal Article
MeSH Terms :
Cilostazol/*metabolism
Phosphodiesterase 3 Inhibitors/*metabolism
Adult ; Biological Availability ; Cilostazol/administration & dosage ; Female ; Humans ; Male ; Pharmacokinetics ; Phosphodiesterase 3 Inhibitors/administration & dosage ; Republic of Korea
Czasopismo naukowe
Tytuł :
Effectiveness comparisons of drug therapies for postoperative aneurysmal subarachnoid hemorrhage patients: network meta‑analysis and systematic review.
Autorzy :
Yu W; Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Huang Y; Department of Endocrinology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Zhang X; Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Luo H; Department of Psychiatry, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Chen W; Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Jiang Y; Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. .
Cheng Y; Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. .
Pokaż więcej
Źródło :
BMC neurology [BMC Neurol] 2021 Jul 27; Vol. 21 (1), pp. 294. Date of Electronic Publication: 2021 Jul 27.
Typ publikacji :
Comparative Study; Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Subarachnoid Hemorrhage*/drug therapy
Subarachnoid Hemorrhage*/etiology
Subarachnoid Hemorrhage*/surgery
Cardiovascular Agents/*therapeutic use
Cilostazol/*therapeutic use
Intracranial Aneurysm/*drug therapy
Neuroprotective Agents/*therapeutic use
Nimodipine/*therapeutic use
Humans ; Intracranial Aneurysm/complications ; Intracranial Aneurysm/surgery ; Network Meta-Analysis ; Postoperative Period ; Prognosis ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Electrospun poly(lactic acid) (PLA)/poly(butylene adipate-co-terephthalate) (PBAT) nanofibers for the controlled release of cilostazol.
Autorzy :
Antunes LR; Master Program in Chemistry, State University of West Paraná, 645, Rua da Faculdade, Paraná, 85903-000 Toledo, Brazil.
Breitenbach GL; Center of Engineering and Exact Sciences, Centro de Engenharias e Ciências Exatas - State University of West Paraná, 645, Rua da Faculdade, Paraná, 85903-000 Toledo, Brazil.
Pellá MCG; Department of Chemistry, State University of Maringá, 5790, Av. Colombo, Paraná 87020-900, Maringá, Brazil. Electronic address: .
Caetano J; Master Program in Chemistry, State University of West Paraná, 645, Rua da Faculdade, Paraná, 85903-000 Toledo, Brazil.
Dragunski DC; Master Program in Chemistry, State University of West Paraná, 645, Rua da Faculdade, Paraná, 85903-000 Toledo, Brazil. Electronic address: .
Pokaż więcej
Źródło :
International journal of biological macromolecules [Int J Biol Macromol] 2021 Jul 01; Vol. 182, pp. 333-342. Date of Electronic Publication: 2021 Mar 30.
Typ publikacji :
Journal Article
MeSH Terms :
Cilostazol/*administration & dosage
Delayed-Action Preparations/*chemistry
Nanofibers/*chemistry
Polyesters/*chemistry
Calorimetry, Differential Scanning ; Spectroscopy, Fourier Transform Infrared ; X-Ray Diffraction
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies